SW2_110A is a rationally designed peptide variant tuned to interrogate a specific protein surface or signaling domain. Substitutions control hydrophobic packing, charge distribution, and secondary-structure propensity. Researchers use it in binding assays and structural analyses to refine interaction models. Applications include PPI mapping, peptide-optimization projects, and mechanistic biochemistry.
CAT No: R2777
Synonyms/Alias:SW2_110A; 2566738-95-0; MS-31354; HY-141716; Unk-Gly(cPent)-D-aIle-Lys(Et2)-Ser-Unk; CS-0201421; G18313; 2579696-95-8; N-[(1S)-1-cyclopentyl-2-[[(2R,3S)-1-[[(2S)-6-(diethylamino)-1-[[(2S)-3-hydroxy-1-oxo-1-(prop-2-ynylamino)propan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-4-phenoxybenzamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.